Jefferies Group LLC Tricida, Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023
BUY
$8.51 - $13.6 $374,440 - $598,400
44,000 Added 55.28%
123,600 $1.3 Million
Q3 2022

Nov 14, 2022
BUY
$8.51 - $13.6 $374,440 - $598,400
44,000 Added 55.28%
123,600 $1.3 Million
Q2 2022

Sep 21, 2023
SELL
$7.31 - $11.85 $321,640 - $521,400
-44,000 Reduced 35.6%
79,600 $770,000
Q2 2022

Aug 15, 2022
BUY
$7.31 - $11.85 $581,876 - $943,260
79,600 New
79,600 $771,000

Others Institutions Holding TCDA

# of Institutions
4
Shares Held
30K
Call Options Held
124K
Put Options Held
46.5K
View Full List

About Tricida, Inc.

TCDA Quotes by TradingView
  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email